JY
RVPH

Jeff Yass’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jeff Yass’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,500
Closed -$18.6K – 14370
2026
Q1 		$18.6K Buy
25,500
+7,045
+38% +$32.1K ﹤0.01% 12872
2025
Q4 		$103K Buy
18,455
+17,780
+2,634% +$198K ﹤0.01% 11434
2025
Q3 		$5K Buy
675
+85
+14% +$722 ﹤0.01% 12132
2025
Q2 		$4.48K Sell
590
-265
-31% -$4.13K ﹤0.01% 12448
2025
Q1 		$16.2K Sell
855
-11,190
-93% -$352K ﹤0.01% 12164
2024
Q4 		$436K Buy
12,045
+11,050
+1,111% +$308K ﹤0.01% 9013
2024
Q3 		$28.7K Sell
995
-785
-44% -$17.4K ﹤0.01% 11543
2024
Q2 		$45.6K Sell
1,780
-935
-34% -$42.5K ﹤0.01% 11452
2024
Q1 		$205K Sell
2,715
-14,685
-84% -$1.16M ﹤0.01% 10549
2023
Q4 		$1.79M Sell
17,400
-5,455
-24% -$490K ﹤0.01% 5602
2023
Q3 		$2.23M Buy
22,855
+15,225
+200% +$1.42M ﹤0.01% 4914
2023
Q2 		$894K Buy
7,630
+1,605
+27% +$203K ﹤0.01% 6958
2023
Q1 		$505K Buy
6,025
+1,455
+32% +$127K ﹤0.01% 8540
2022
Q4 		$388K Sell
4,570
-840
-16% -$64.1K ﹤0.01% 8459
2022
Q3 		$172K Buy
+5,410
New +$149K ﹤0.01% 11058

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Jeff Yass's RVPH Position: Q1 2026 in Review

Jeff Yass sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 34,103 shares — an estimated $155K sold.

Jeff Yass first reported a position in RVPH in Q3 2021 and held it in 15 quarters. The position peaked at $1.06M in Q4 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Jeff Yass reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 34,103 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $155K.
  • Jeff Yass first reported a position in REVIVA PHARMA HLDGS INC in Q3 2021 and held it in 15 quarters.
  • Jeff Yass's REVIVA PHARMA HLDGS INC position peaked at $1.06M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.